Evidence map›Paper›PMID 37754896›Full record

ArticleJournal of functional biomaterials2023

Polyacrylate-Cholesterol Amphiphilic Derivative: Formulation Development and Scale-up for Health Care Applications.

Marco Viola, Claudia Migliorini, Fabio Ziarelli, Stéphane Viel, Claudia Cencetti, Daniel Di Risola, Luciana Mosca, Laura Masuelli, Pietro Matricardi, Chiara Di Meo

Abstract read
In one paragraph

Article in Journal of functional biomaterials, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Marco ViolaDepartment of Drug Chemistry and Technologies, Sapienza University of Rome, 00185 Rome, Italy.
Claudia MiglioriniDepartment of Drug Chemistry and Technologies, Sapienza University of Rome, 00185 Rome, Italy.
Fabio ZiarelliAix-Marseille Université, CNRS, Centrale Méditerranée, Fédération Sciences Chimiques Marseille, 13013 Marseille, France.ORCID 0000-0002-0050-9689
Stéphane VielAix-Marseille Université, CNRS, Institut de Chimie Radicalaire, 13013 Marseille, France.
Claudia CencettiQI SRL, Pomezia, 00071 Rome, Italy.
Daniel Di RisolaDepartment of Biochemical Sciences "A. Rossi Fanelli", Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0001-6441-5668
Luciana MoscaDepartment of Biochemical Sciences "A. Rossi Fanelli", Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0003-2748-9021
Laura MasuelliDepartment of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy.
Pietro MatricardiDepartment of Drug Chemistry and Technologies, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0003-2086-911X
Chiara Di MeoDepartment of Drug Chemistry and Technologies, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0002-3531-6107

Funding

Sapienza University of Rome RM120172AE742B3B
6 · The paper itself

Abstract

The novel amphiphilic polyacrylate grafted with cholesterol moieties, PAAbCH, previously synthesized, was deeply characterized and investigated in the lab and on a pre-industrial scale. Solid-state NMR analysis confirmed the polymer structure, and several water-based pharmaceutical and cosmetic products were developed. In particular, stable oil/water emulsions with vegetable oils, squalene, and ceramides were prepared, as well as hydrophilic medicated films loaded with diclofenac, providing a prolonged drug release. PAAbCH also formed polyelectrolyte hydrogel complexes with chitosan, both at the macro- and nano-scale. The results demonstrate that this polymer has promising potential as an innovative excipient, acting as a solubility enhancer, viscosity enhancer, and emulsifying agent with an easy scale-up transfer process.

Indexed as

amphiphiliccholesterolemulsifierpolyacrylatesolid-state NMRtopical formulations

Identifiers

PMID37754896
PMCPMC10532428

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.